English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCardiovascular disease and cancer, the nation’s top two killers, share common ground like obesity and chronic inflammation, as well as a disproportionate impact on Black Americans. A new American Heart Association-funded center at the Medical College of Georgia is working…
Tag: Breast Cancer
Change Agent
The UNM Comprehensive Cancer Center helps patients with high-complexity cases. Elyse Eckart’s experience with breast cancer has led her to take on new challenges and embrace tasks and activities she may not have before. She’s also giving back to the community.
Hundreds of chemicals, many in consumer products, could increase breast cancer risk
List includes potential carcinogens that act by stimulating production of hormones that fuel breast tumors
New approach eradicates breast cancer in mice
CHAMPAIGN, Ill. — A new approach to treating breast cancer kills 95-100% of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called ErSO, quickly shrinks…
Program seeks to reduce preventable cancers with free screening, same-day results
George Mason faculty Michelle Williams leads program evaluation determining feasibility of See, Test, & Treat Program to addresses barriers and improve health outcomes for cervical, breast, and oral cancer among under-served women in Mississippi
Can turmeric reduce joint pain during breast cancer treatment?
The UC Davis Comprehensive Cancer Center received a $50,000 grant from the Safeway Foundation. The funding will allow researcher Mili Arora to study whether the spice turmeric can provide pain relief for breast cancer patients on oral anti-estrogen drugs.
Routine screening for BI-RADS lesions on automated whole-breast ultrasound
Return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast ultrasound substantially reduces the recall rate, while being unlikely to result in adverse outcome
New WHO study links moderate alcohol use with higher cancer risk
One in four new breast cancers and one in five colon cancers in Canada attributed to alcohol
COVID precautions may result in more breast cancer deaths
A new paper in the Journal of the National Cancer Institut e, published by Oxford University Press, indicates that disruptions in health care due to the COVID 19 pandemic may increase breast cancer deaths. In March 2020 public health measures…
Promising new research on aggressive breast cancer
Better treatments of HER2-positive breast cancer are closer at hand, thanks to new research by a team led by Université de Montréal professor Jean-François Côté at the cytoskeleton organization and cell-migration research unit of the UdeM-affiliated Montreal Clinical Research Institute.…
New breast cancer skills program for patients released by American College of Surgeons
The American College of Surgeons (ACS) Surgical Skills Patient Education Program has launched a new kit for breast cancer patients that will help guide them from diagnosis to recovery. The ACS Surgical Skills Patient Education Program provides evidence-based knowledge, checklists, and skills training to support patients with preparation for surgery and optimal recovery.
Susan G. Komen® awards $600,000 research grant to radiology chair Elizabeth Morris
Department of Radiology Chair Elizabeth Morris, with the UC Davis Comprehensive Cancer Center, was awarded a Susan G. Komen® grant to develop artificial intelligence models to predict breast cancer risk at a more personalized level
Assured Resolution
UNM Comprehensive Cancer Center conducted a two-pronged study looking into the efficacy of 3D mammograms and also the general awareness of the technology among at-risk populations in New Mexico. The study was conducted prior to the technology gaining more use among the public, and showed fewer callbacks and more awareness even in its early days.
American Society for Radiation Oncology (ASTRO) to host Annual Meeting in Chicago 10/24-27
#ASTRO21 will be the first major medical conference in the city; a curated digital program also will be offered for remote attendees
New computational technique, software identifies cell types within a tumor and its microenvironment
Offers an analytical approach that has no equivalents in the current bioinformatics/systems biology toolbox
Study explores opioid prescribing preferences and practices among residents and faculty
CU Department of Surgery’s Victoria Huynh, MD, and Sarah Tevis, MD, are developing new protocols to improve surgical recovery
Triple-negative breast cancer metastases in lungs contain more diverse cells than those in liver
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
Potential Drug Target for Difficult-To-Treat Breast Cancer: RNA-Binding Proteins
UC San Diego studies using human cell lines and tumors grown in mice provide early evidence that inhibiting RNA-binding proteins, a previously overlooked family of molecules, might provide a new approach for treating some cancers.
Women’s use of preventive health services during COVID-19
What The Study Did: Changes in the use of women’s preventive health services during the COVID-19 pandemic, including screening for sexually transmitted infections, breast and cervical cancer, and obtaining contraceptives from pharmacies are described by researchers in this study. Authors:…
NYUAD study maps nanobody structure, leading to new ways to potentially fight diseases
Fast facts: Nanobodies have been shown to inhibit the dysfunction of key proteins involved with various diseases such as rheumatoid arthritis, osteoarthritis, psoriasis, B-cell lymphoma, and breast cancer Understanding the structure of a nanobody helps to better understand its disease-fighting…
Gap in breast cancer mortality rates between Black and white women has narrowed
Black women still have twice the rate of breast cancer death than their white counterparts
Reactive oxygen species (ROS): Key components in cancer therapies
The article by Dr. Biswa Mohan Sahoo et al. is published in Anti-Cancer Agents in Medicinal Chemistry, 2021
Hackensack University Medical Center Breast Surgeons Demonstrate Accuracy of New Technology for Marking Location of Cancerous Lymph Nodes
Breast surgeons at Hackensack Meridian Hackensack University Medical Center have a new tool that allows them to pinpoint breast tumors more easily, with many benefits to the patient.
Radiologist Characteristics Predict Performance in Screening Mammography
According to a new study, by the Harvey L. Neiman Health Policy Institute and the American College of Radiology’s National Mammography Database Committee, the most influential radiologist characteristics impacting mammography interpretive performance were geography, breast sub-specialization, performance of diagnostic mammography, and performance of diagnostic ultrasound.
Study examines how breast implant surfaces affect immune response
Rice University bioengineers collaborated on a six-year study that systematically analyzed how the surface architecture of breast implants influences the development of adverse effects, including an unusual type of lymphoma.
Study Shows Immunotherapy Drug Combination Improves Response in HER2-Negative Breast Cancer Including a Subset of Estrogen Receptor Positive Cancers
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.
Natural killers: Using the body’s cells to target breast cancer
The research utilizes the body’s natural killer cells, part of the human immune system, to target breast cancer tumor cells. The triggers are fusion proteins developed by Clemson University researchers that link the two together. The research is a novel approach to developing breast cancer-specific immunotherapy.
Small Numbers of Cells in a Tumor Could Be Key Enablers of Cancer Metastasis
Just a small number of cells found in tumors can enable and recruit other types of cells nearby, allowing the cancer to spread to other parts of the body, report Georgetown Lombardi Comprehensive Cancer Center scientists. Working with their research collaborators, the scientists found that ‘enabler cells’ comprise about 20 percent or less of the cells in an aggressive tumor; their small numbers may account for why they are often missed when bulk tissue analyses are used to inform therapeutic decisions.
Natural killers: Using the body’s cells to target breast cancer
Study lays groundwork for possible new immunotherapy for the world’s most commonly diagnosed cancer
Women leaving jail have high vaccine hesitancy; app drops resistance, boosts literacy
Vulnerable population offers keys to better communications on vaccines, researchers argue
Black and White Women Have Same Mutations Linked to Breast Cancer Risk
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same.
Trapping DNA damage
Untangling the proteins that trigger some cancerous tumors
COVID-19 vaccine hesitancy among patients with breast cancer
What The Study Did: This survey study among women with breast cancer in Mexico evaluates their specific concerns about and high hesitancy rate toward COVID-19 vaccination. Authors: Cynthia Villarreal-Garza, M.D., D.Sc., of the Breast Cancer Center, Hospital Zambrano Hellion TecSalud…
Breast Cancer Study: African Americans Not Experiencing Complete Response to Extent Other Groups Are
Researchers at Roswell Park Comprehensive Cancer Center led the largest study to date to suggest an improving trend in pathologic complete response rates over time for U.S. cancer patients of various races. The team’s findings, documented in a poster presentation at the 2021 American Society of Clinical Oncology virtual annual meeting (abstract 575), show that African Americans are more likely than patients from any other group to have remaining disease following breast cancer treatment.
Cholesterol metabolite induces production of cancer-promoting vesicles
CHAMPAIGN, Ill. — Scientists working to understand the cellular processes linking high cholesterol to breast cancer recurrence and metastasis report that a byproduct of cholesterol metabolism causes some cells to send out cancer-promoting signals to other cells. These signals are…
Breast cancer risk in African-Americans tied to genetic variations
Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian investigators. The study…
Internationally Renowned Breast Cancer and HIV-Associated Malignancy Expert to Join Mount Sinai
Mount Sinai Health System has recruited an internationally recognized expert in the management of breast cancer and HIV-associated malignancies, Joseph A. Sparano, MD, FACP, as Chief of Hematology and Medical Oncology and Deputy Director of The Tisch Cancer Institute (TCI). Dr. Sparano will also hold the Ezra M. Greenspan, MD Professorship in Clinical Cancer Therapeutics at the Icahn School of Medicine at Mount Sinai and will oversee the expansion of clinical and research capacities of the Division and TCI.
First in the World! Chulalongkorn Hospital Successfully Treats a Breast Cancer Patient with Immunotherapy
Queen Sirikit Center for Breast Cancer, King Chulalongkorn Memorial Hospital, Thai Red Cross Society (Chulalongkorn Hospital) has become the world’s first institution to have successfully used immunotherapy to treat a breast cancer patient who is now in complete remission with minimal side effects and uplifted quality of life.
Diets that Promote Inflammation Could Increase Breast Cancer Risk
A new study of more than 350,000 women found that women with diets incorporating more foods that increase inflammation in the body had a 12% increase in their risk of breast cancer compared to women who consume more anti-inflammatory diets.
Oncotarget: The drug sensitivity of hepatocellular cancer cells
‘Hepatocellular carcinoma (HCC) is the third leading cause of cancer related death worldwide, with a poor median survival time after diagnosis of six months’
Increase in Advanced Breast Cancer Diagnoses During COVID-19 Pandemic
Reporting at the 2021 annual meeting of the American Society of Clinical Oncology, Kathryn A. Gold, MD, associate clinical professor at University of California San Diego School of Medicine, presented data showing a decrease in people diagnosed with early stage…
New findings offer improved therapy of early-stage, BRCA mutation-associated breast cancer
Results were released this week on a new treatment with the potential to improve the outcomes for patients with hereditary BRCA mutations and high-risk, early-stage breast cancer. These results represent the first time a drug that blocks cancer cells from repairing their DNA (called a PARP inhibitor) has been shown to significantly reduce the risk of breast cancer returning in high-risk patients following completion of standard chemotherapy, surgery and radiation therapy.
New method predicts chemotherapy effectiveness after one treatment
Interdisciplinary team finds combining certain data after a patient’s first treatment can predict how a tumor will respond to chemotherapy.
Researchers Find Evidence That Diet Can Alter the Microbiome to Affect Breast Cancer Risk
New research shows that diet, including fish oil supplements, can alter not only the breast microbiome, but also breast cancer tumors. The study appears online in Cancer Research, a journal of the American Association for Cancer Research.
Breast cancer patients embrace integrative health during treatment
National survey finds oncologists underestimate patient use of complementary and lifestyle therapies
New tech predicts chemotherapy effectiveness after one treatment
Early prediction of treatment efficacy may help improve quality of life for people with breast cancer
Oncotarget: E6-specific inhibitors as therapeutics for HPV+ head and neck carcinomas
‘Head and neck squamous cell carcinomas (HNSCC) are heterogeneous tumors that arise in the upper respiratory tract and are the 6th most common cancer worldwide by incidence’
Oncotarget: Lung squamous cell carcinoma tumors reveal therapeutic alterations
Lung cancer is the leading cause of cancer-related deaths across the globe with more than 1.7 million deaths annually’
Researchers identify how to prevent cancer metastases
Metastases can develop in the body even years after apparently successful cancer treatment. They originate from cancer cells that migrated from the original tumor to other organs, and which can lie there inactive for a considerable time. Researchers have now…
Featured research from NUTRITION 2021 LIVE ONLINE
Press materials for virtual event now available